Loading company…
MARS Bioimaging develops spectral photon-counting CT systems for medical and research imaging.
MARS Bioimaging develops spectral photon-counting CT systems for preclinical research and diagnostic imaging. Its MARS Microlab 5X120 uses Medipix3RX detector technology to produce high-resolution color CT images. Founded in 2007 by Phil Butler and Prof Anthony Butler, the company is based in Christchurch, New Zealand. In January 2026, it raised USD 7.4 million in Series A funding led by Pacific Channel.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in